News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Amol Akhade: Must-Read for All – Oncologists and Non Oncologists
Amol Akhade/hiranandanihospital.org
Jun 9, 2025, 07:49

Amol Akhade: Must-Read for All – Oncologists and Non Oncologists

Amol Akhade, Consultant Medical Oncologist at the Suyog Cancer Clinics, posted on X:

“The Semmelweis Reflex = the knee-jerk rejection of new evidence that challenges established norms. Dr. Lutz Kraushaar breaks all the criticism of Challenge Trial point by point.
Must-read for all – oncologist and non oncologist.”

More posts featuring Amol Akhade.

Amol Akhade cancer Lutz Kraushaar OncoDaily Oncology
Special Coverage
Blog
Jun 9, 2025, 07:49
Amol Akhade: Must-Read for All - Oncologists and Non Oncologists
Blog
Jun 9, 2025, 07:45
Register today for ESMO Immuno-Oncology Annual Congress - European Society for Medical Oncology
Blog
Jun 9, 2025, 07:43
Dana-Farber’s Breast Oncology Center - Novel and Emerging Treatment Options in ER+/HER2− Metastatic Breast Cancer
Science
Jun 9, 2025, 07:29
Diego Díaz García Highlights LAG-3 as Emerging Checkpoint Target in Melanoma
Blog
Jun 9, 2025, 07:23
Aaron Goodman Reflects on Discomfort and Imposter Syndrome in Medical Practice
Blog
Jun 9, 2025, 07:12
Yan Leyfman: Are Immune Checkpoint Inhibitors Safe for Patients with Neurologic Autoimmune Disorders?
Blog
Jun 9, 2025, 07:07
Paolo Tarantino Raises Poll on Chemotherapy Attrition in Metastatic Breast Cancer
Blog
Jun 9, 2025, 05:26
Diego Sadler Reports FDOH Grant for Cancer Innovation to GCOR
Blog
Jun 9, 2025, 05:19
Last call to apply for the ECLIPTIC Programme - European School of Oncology
Blog
Jun 9, 2025, 05:06
Voice of the families: Chilot and his father, Woldie Asemaraw - CANCaRe Africa
Blog
Jun 9, 2025, 04:47
Bar Levy: Reflections from ASCO 2025 - What should Patient Advocates Take from these Findings?
Insight
Jun 9, 2025, 04:36
Rohan Garje: Avelumab and taxol chemotherapy in platinum-refractory or ineligible metastatic urothelial carcinoma